HCA Healthcare increased the maximum aggregate principal amount of its unsecured commercial paper program from $4.0 billion to $8.0 billion on July 29, 2026. The notes are issued by a wholly owned subsidiary and are unconditionally guaranteed by HCA Healthcare, Inc., with terms remaining consistent with previous disclosures. This expansion of short-term borrowing capacity is material as it significantly alters the company's liquidity profile and debt management strategy. HCA Healthcare operates in the healthcare industry, specifically owning and operating hospitals, freestanding surgery centers, and urgent care facilities.

HCA Healthcare, Inc. reported second quarter 2026 results with revenues of $20.230 billion, an 8.7 percent increase year-over-year, and net income of $1.699 billion. The company's board of directors declared a quarterly cash dividend of $0.78 per share, payable on September 30, 2026, to stockholders of record as of September 16, 2026. HCA Healthcare, Inc. operates in the healthcare industry and provides hospital and ambulatory care services.

HCA Healthcare, Inc. issued a press release on July 14, 2026, announcing its preliminary results of operations for the second quarter ended June 30, 2026. HCA Healthcare, Inc. operates in the healthcare industry and provides hospital and surgical center services.

Dr. Michael Cuffe will step down from his position as Executive Vice President and Chief Clinical Officer effective August 31, 2026, transitioning to a transitional role until February 2027. He will receive benefits under the company's executive severance policy and incentive plans. HCA Healthcare, Inc. is a healthcare services provider operating in the healthcare industry.

HCA Inc., a subsidiary of HCA Healthcare, Inc., completed a $3 billion public offering of senior unsecured notes on April 30, 2026. The issuance consists of $1 billion in 4.7% notes due 2031, $750 million in 5.0% notes due 2033, and $1.25 billion in 5.3% notes due 2036.